New US customer interaction center opens in Massachusetts’ Waltham Biotech Hub with 3rd annual Mass Photometry Summit set to highlight latest advances Refeyn’s new US headquarters to open in Massachusetts in Waltham’s Biotech Hub. Oxford, UK – Refeyn, the pioneer of mass photometry technology, is continuing to strengthen the deployment of its unique bioanalytical tools […]
The Hospital will enhance its testing and research of blood cancers with the SOPHiA DDM™ Platform Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Instituto Mário Penna is live on the SOPHiA DDM™ Platform. Located in Belo Horizonte, Brazil, […]
Ms. Richo brings more than 30 years of global legal, compliance, and regulatory experience to Illumina’s Board SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) announced today that Anna Richo has joined the company’s Board of Directors following shareholder approval of the director slate at the company’s May 16, 2024, annual meeting. Ms. Richo currently serves as […]
Tokyo – Hitachi High-Tech Corporation (“Hitachi High-Tech”) and Hitachi, Ltd. (“Hitachi”) announced a collaborative creation (“co-creation”) that utilizes the Materials Informatics (“MI”) solutions provided by the Hitachi Group on the “MACSiMUM*”, AI and machine learning platform, operated by Industrial Technology Research Institute (“ITRI”), the largest industrial technology research and development organization in Taiwan. With supported […]
Saint-Germain-en-Laye, France – Takara Bio announces the launch of PrimeCap™ T7 RNA Polymerase (low dsRNA), a mutant T7 RNA polymerase suitable for mRNA therapeutic research and development. PrimeCap T7 RNA Polymerase is a mutant T7 RNA polymerase that has been genetically engineered to maintain high-performance RNA synthesis activity while reducing dsRNA production to less than […]
The SOPHiA DDM™ Platform will help broaden the hospital’s cancer testing and diagnostic capabilities Boston, MA and Rolle, Switzerland – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that Klinikum Klagenfurt am Wörthersee, the third largest hospital in Austria, is live on the SOPHiA DDM™ Platform. The hospital will use […]
Strategic partnership enables companies to combine technology offerings and streamline NGS workflows CORALVILLE, Iowa and HEIDELBERG, Germany — Genomics solutions provider Integrated DNA Technologies (IDT) and Bio-IT company Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their next generation sequencing (NGS) capabilities. The partnership pairs IDT’s Archer NGS […]
Consortium Selects Leading Genomics Companies to Support Pediatric Mendelian Genomics Research Center Program ALISO VIEJO, Calif. and MENLO PARK, Calif. — Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced their companies’ […]
The Applied Biosystems™ Axiom™ BloodGenomiX™ Array and Software provide a high-throughput solution for more precise blood matching research WALTHAM, Mass. — Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Applied Biosystems™ Axiom™ BloodGenomiX™ Array* and Software, a first-of-its-kind solution for more precise blood genotyping in clinical research. The new array detects […]
As the first NGS interpretation platform for both oncology and hereditary applications, the updated version of QIAGEN Clinical Insight Interpret is approved for diagnostic use Regulatory framework ensures greater patient protection, transparency of information, and traceability of data Over 4 million NGS patient test cases for oncology and hereditary diseases worldwide processed with QIAGEN Clinical […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
